Skip to main content
. 2020 Mar 26;23(2):205–217. doi: 10.4048/jbc.2020.23.e22

Table 1. Demographics and clinical characteristics.

Parameter Exp. (n = 19) Cont. (n = 21) χ2 or t (p value)
Mean ± SD (range) or No. (%) Mean ± SD (range) or No. (%)
Age (years)* 49.95 ± 8.12 (34–67) 48.14 ± 6.67 (33–62)
≤ 39 1 (5.3) 2 (9.5) 2.280 (0.623)
40–49 9 (47.4) 10 (47.6)
50–59 7 (36.8) 9 (42.9)
≥ 60 2 (10.5) -
Marital status 0.007 (0.935)
Married 12 (63.2) 13 (61.9)
Single/widowed/divorced 7 (36.8) 8 (38.1)
Income (KRW) 0.973 (0.324)
< 3 million 12 (63.2) 10 (47.6)
≥ 3 million 7 (36.8) 11 (52.4)
Employment status 1.069 (0.301)
No 13 (68.4) 11 (52.4)
Yes 6 (31.6) 10 (47.6)
Religion 0.043 (0.836)
No 6 (31.6) 6 (28.6)
Yes 13 (38.4) 15 (71.4)
Economic burden 2.431 (0.119)
No 8 (42.1) 14 (66.3)
Yes 11 (57.9) 7 (33.4)
Education level 2.824 (0.093)
≤ High school 14 (73.7) 10 (47.6)
≥ College 5 (26.3) 11 (52.4)
Children* 0.302 (0.712)
No 5 (26.3) 4 (19.0)
Yes 14 (73.7) 17 (81.0)
Stage 1.269 (0.530)
I 4 (21.1) 7 (33.4)
II 10 (52.6) 11 (52.4)
III 5 (26.3) 3 (14.2)
Surgery type 0.935 (0.334)
Mastectomy 3 (31.6) 6 (28.6)
Breast conservation 16 (68.4) 15 (71.4)
Time since diagnosis (years)* 0.974 (0.674)
< 1 6 (31.6) 9 (42.9)
1–2 11 (57.9) 9 (42.9)
≥ 2 2 (10.5) 3 (14.2)
Chemotherapy* 1.905 (0.488)
None - 2 (9.5)
Completed 19 (100) 19 (90.5)
Radiation therapy* 1.778 (0.738)
None - 2 (9.5)
Completed 18 (94.7) 18 (85.7)
Currently 1 (5.3) 1 (4.8)
Endocrine therapy 0.082 (0.775)
No 10 (52.6) 12 (57.2)
Yes 9 (47.4) 9 (42.8)
Target therapy* 2.899 (0.217)
No 11 (57.9) 17 (81.0)
Yes 7 (36.8) 4 (19.0)
Unknown 1 (5.3) -
Triple-negative* 1.655 (0.525)
No 13 (68.4) 12 (57.1)
Yes 5 (26.3) 5 (23.8)
Unknown 1 (5.3) 4 (19.1)

Cont = control group; Exp = experimental group; SD = standard deviation; KRW = Korean Won.

*Fisher's exact test.